Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
ALTEPLASE 50 MG INTRAVENOUS SOLUTION (NDC 50242004406_2) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 24, 2026 , from http://ppman.hank.ai/transparency/procedure/50242004406_2/by-state?code_type=NDC
“ALTEPLASE 50 MG INTRAVENOUS SOLUTION (NDC 50242004406_2) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/50242004406_2/by-state?code_type=NDC. Accessed
October 24, 2026 .
“ALTEPLASE 50 MG INTRAVENOUS SOLUTION (NDC 50242004406_2) by State,” HANK Price Transparency ,
accessed October 24, 2026 ,
http://ppman.hank.ai/transparency/procedure/50242004406_2/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
50242004406_2 — Alteplase 50 Mg Intravenous Solution
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$6,955
National median
$4,632 – $8,399
IQR (p25 – p75)
3
hospitals filing
2
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 50242004406_2 (NDC), with interquartile range
State Median p25 p75
AL $8,088 $6,034 $10,919
MI $6,955 $4,846 $8,293